Yarrow Bioscience (YARW) Free Cash Flow by Year
Yarrow Bioscience, Inc. recorded an outflow of $33.1M in free cash flow in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 11 fiscal years, from 2015 to 2025.
Ticker history: VYNE became YARW (Yarrow Bioscience, Inc.) on . Earlier news and filings retain their original names and dates. View VYNE history.
Annual figures, oldest first. Point at a bar to read its period.
YARW Free Cash Flow by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Yarrow Bioscience, Inc. financials
Frequently Asked Questions
Yarrow Bioscience, Inc. recorded an outflow of $33.1M in free cash flow in fiscal year 2025.
Yarrow Bioscience, Inc. (YARW) reported an outflow of $34.1M in free cash flow in fiscal year 2024 and an outflow of $33.1M in free cash flow in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Across the 11 fiscal years this page covers, Yarrow Bioscience, Inc. (YARW) free cash flow went from -$4.2M in fiscal year 2015 to -$33.1M in fiscal year 2025.
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Yarrow Bioscience, Inc. (YARW) reported on that line in every period on record.